Similar articles

• Re: Is a screening interval of every 4 years for prostate cancer acceptable?

  Roobol MJ, Schröder FH. Roobol MJ, et al. J Natl Cancer Inst. 2008 Feb 6;100(3):222; author reply 223-4. doi: 10.1093/jnci/djm293. Epub 2008 Jan 29. J Natl Cancer Inst. 2008. PMID: 18230797 No abstract available.
• Prostate specific antigen and screening for early prostate cancer.

  Davidson P. Davidson P. N Z Med J. 2001 Apr 13;114(1129):150. N Z Med J. 2001. PMID: 11400919 No abstract available.
• Interval cancers in prostate cancer screening: comparing 2- and 4-year screening intervals in the European Randomized Study of Screening for Prostate Cancer, Gothenburg and Rotterdam.

  Roobol MJ, Grenabo A, Schröder FH, Hugosson J. Roobol MJ, et al. J Natl Cancer Inst. 2007 Sep 5;99(17):1296-303. doi: 10.1093/jnci/djm101. Epub 2007 Aug 28. J Natl Cancer Inst. 2007. PMID: 17728218 Clinical Trial.
• PSA-based screening for prostate cancer: how does it compare with other cancer screening tests?

  Crawford ED, Abrahamsson PA. Crawford ED, et al. Eur Urol. 2008 Aug;54(2):262-73. doi: 10.1016/j.eururo.2008.05.032. Epub 2008 May 27. Eur Urol. 2008. PMID: 18556114 Review.
• What to do with an abnormal PSA test.

  Loeb S, Catalona WJ. Loeb S, et al. Oncologist. 2008 Mar;13(3):299-305. doi: 10.1634/theoncologist.2007-0139. Oncologist. 2008. PMID: 18378540 Review.